Thalidomide treatment for hypertrophic cutaneous lupus erythematosus

Journal of Dermatological Treatment

Volumn 15, Issue 6, 2004, Pages 365-371

  Gambini, Daniele ^a   Carrera, C ^a   Passoni, E ^a   Muratori, S ^a   Berti, E ^b   Caputo, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cutaneous lupus erythematosus; Thalidomide; Therapy

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; THALIDOMIDE;

ADULT; AGED; CLINICAL ARTICLE; CONCENTRATION LOSS; CORTICOSTEROID THERAPY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SEDATION; SKIN LUPUS ERYTHEMATOSUS; TREMOR; WEIGHT GAIN;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; THALIDOMIDE;

EID: 10644244376     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630410018094     Document Type: Review

References (16)

1. Mellin GW, The saga of thalidomide. N Engl J Med (1962) 267: 1184-93.
2. Mellin GW, The saga of thalidomide (concluded). N Engl J Med (1962) 267: 1238-44.
3. Wines N, Cooper A, Wines M, Thalidomide in dermatology. Australas J Dermatol (2002) 43: 229-40.
4. Beçt PE, Hypertrophic lupus erythematosus. Arch Derm Syph (1940) 42: 211-20.
5. John MD, Gruber GG, Turner JE et al, Lupus erythematosus hypertrophicus. Cutis (1981) 28: 290-2.
6. Santa Cruz DJ, Uitto J, Eizen AZ et al, Verrucous lupus erythematosus: ultrastructural studies on a distinct variant of chronic discoid lupus erythematosus. J Am Acad Dermatol (1983) 9: 82-90.
7. Rubenstein DJ, Huntley AC, Keratotic lupus erythematosus: treatment with isotretinoin. J Am Acad Dermatol (1986) 14: 910-14.
8. Knop J, Bonsmann G, Happle R et al, Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol (1983) 108: 461-6.
9. Duong DJ, Spigel GT, Moxley RT, Gaspari AA, American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus. Arch Dermatol (1999) 135: 1079-87.
10. Kyriakis KP, Kontochristopoulos GJ, Panteleos DN, Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus. Int J Dermatol (2000) 39: 218-22.
11. Housman TS, Jorizzo JL, McCarty MA et al, Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol (2003) 139: 50-4.
12. Thomson KF, Goodfield MJ, Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus. J Dermatolog Treat (2001) 12: 145-7.
13. Moraes M, Russo G, Thalidomide and its dermatologic uses. Am J Med Sci (2001) 321: 321-6.
14. Ordi-Ros J, Cortes F, Cucurull E et al, Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol (2000) 27: 1429-33.
15. Bohmeyer J, Achenbach A, Westenberger M et al, Thalidomide therapy of cutaneous lupus erythematosus. Hautarzt (2002) 53: 744-8.
16. Georgala S, Katoulis AC, Hasapi V, Koumantaki-Mathioudaki E, Thalidomide treatment for hypertrophic lupus erythematosus. Clin Exp Dermatol (1998) 23: 141.